270 related articles for article (PubMed ID: 23940300)
1. Nm23-h1 binds to gelsolin and inactivates its actin-severing capacity to promote tumor cell motility and metastasis.
Marino N; Marshall JC; Collins JW; Zhou M; Qian Y; Veenstra T; Steeg PS
Cancer Res; 2013 Oct; 73(19):5949-62. PubMed ID: 23940300
[TBL] [Abstract][Full Text] [Related]
2. Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer.
Marshall JC; Collins JW; Nakayama J; Horak CE; Liewehr DJ; Steinberg SM; Albaugh M; Vidal-Vanaclocha F; Palmieri D; Barbier M; Murone M; Steeg PS
J Natl Cancer Inst; 2012 Sep; 104(17):1306-19. PubMed ID: 22911670
[TBL] [Abstract][Full Text] [Related]
3. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.
Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS
J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434
[TBL] [Abstract][Full Text] [Related]
4. Metastasis suppressor function of NM23-H1 requires its 3'-5' exonuclease activity.
Zhang Q; McCorkle JR; Novak M; Yang M; Kaetzel DM
Int J Cancer; 2011 Jan; 128(1):40-50. PubMed ID: 20209495
[TBL] [Abstract][Full Text] [Related]
5. Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells.
Boissan M; De Wever O; Lizarraga F; Wendum D; Poincloux R; Chignard N; Desbois-Mouthon C; Dufour S; Nawrocki-Raby B; Birembaut P; Bracke M; Chavrier P; Gespach C; Lacombe ML
Cancer Res; 2010 Oct; 70(19):7710-22. PubMed ID: 20841469
[TBL] [Abstract][Full Text] [Related]
6. Nm23-H1 inhibits lung cancer bone-specific metastasis by upregulating miR-660-5p targeted SMARCA5.
Ai C; Ma G; Deng Y; Zheng Q; Gen Y; Li W; Li Y; Zu L; Zhou Q
Thorac Cancer; 2020 Mar; 11(3):640-650. PubMed ID: 32022430
[TBL] [Abstract][Full Text] [Related]
7. H-prune-nm23-H1 protein complex and correlation to pathways in cancer metastasis.
Garzia L; Roma C; Tata N; Pagnozzi D; Pucci P; Zollo M
J Bioenerg Biomembr; 2006 Aug; 38(3-4):205-13. PubMed ID: 17103319
[TBL] [Abstract][Full Text] [Related]
8. Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2.
Horak CE; Mendoza A; Vega-Valle E; Albaugh M; Graff-Cherry C; McDermott WG; Hua E; Merino MJ; Steinberg SM; Khanna C; Steeg PS
Cancer Res; 2007 Dec; 67(24):11751-9. PubMed ID: 18089805
[TBL] [Abstract][Full Text] [Related]
9. Nm23-H1 suppresses hepatocarcinoma cell adhesion and migration on fibronectin by modulating glycosylation of integrin beta1.
She S; Xu B; He M; Lan X; Wang Q
J Exp Clin Cancer Res; 2010 Jul; 29(1):93. PubMed ID: 20618991
[TBL] [Abstract][Full Text] [Related]
10. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
[TBL] [Abstract][Full Text] [Related]
11. CTCF and EGR1 suppress breast cancer cell migration through transcriptional control of Nm23-H1.
Wong KM; Song J; Wong YH
Sci Rep; 2021 Jan; 11(1):491. PubMed ID: 33436746
[TBL] [Abstract][Full Text] [Related]
12. [Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1].
Che GW; Zhou QH; Zhu W; Wang YP; Qin Y; Liu LX; Chen XH; Sun YL; Sun ZF
Ai Zheng; 2005 Mar; 24(3):278-84. PubMed ID: 15757527
[TBL] [Abstract][Full Text] [Related]
13. Metastasis Suppressors NME1 and NME2 Promote Dynamin 2 Oligomerization and Regulate Tumor Cell Endocytosis, Motility, and Metastasis.
Khan I; Gril B; Steeg PS
Cancer Res; 2019 Sep; 79(18):4689-4702. PubMed ID: 31311812
[TBL] [Abstract][Full Text] [Related]
14. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981.
Che G; Chen J; Liu L; Wang Y; Li L; Qin Y; Zhou Q
Neoplasma; 2006; 53(6):530-7. PubMed ID: 17167724
[TBL] [Abstract][Full Text] [Related]
15. nm23-H1 is a negative regulator of TGF-β1-dependent induction of epithelial-mesenchymal transition.
Zhao R; Gong L; Li L; Guo L; Zhu D; Wu Z; Zhou Q
Exp Cell Res; 2013 Mar; 319(5):740-9. PubMed ID: 23137649
[TBL] [Abstract][Full Text] [Related]
16. Alteration in gene expression profile and biological behavior in human lung cancer cell line NL9980 by nm23-H1 gene silencing.
Ma W; Chen J; Xue X; Wang Z; Liu H; Wang T; Bai Y; Tang SC; Zhou Q
Biochem Biophys Res Commun; 2008 Jul; 371(3):425-30. PubMed ID: 18440302
[TBL] [Abstract][Full Text] [Related]
17. ATF3 suppresses metastasis of bladder cancer by regulating gelsolin-mediated remodeling of the actin cytoskeleton.
Yuan X; Yu L; Li J; Xie G; Rong T; Zhang L; Chen J; Meng Q; Irving AT; Wang D; Williams ED; Liu JP; Sadler AJ; Williams BR; Shen L; Xu D
Cancer Res; 2013 Jun; 73(12):3625-37. PubMed ID: 23536558
[TBL] [Abstract][Full Text] [Related]
18. Nm23-H1 homologs suppress tumor cell motility and anchorage independent growth.
McDermott WG; Boissan M; Lacombe ML; Steeg PS; Horak CE
Clin Exp Metastasis; 2008; 25(2):131-8. PubMed ID: 18058029
[TBL] [Abstract][Full Text] [Related]
19. [Lentivirus-mediated stable silencing of nm23-H1 gene in lung cancer cells and the influence on biological behavior].
Luo M; Zhu D; Gong L; Qiu X; Zu L; Sun L; Wu Z; Zhou Q
Zhongguo Fei Ai Za Zhi; 2012 Mar; 15(3):139-45. PubMed ID: 22429576
[TBL] [Abstract][Full Text] [Related]
20. Interaction of the tumor metastasis suppressor nonmetastatic protein 23 homologue H1 and estrogen receptor alpha alters estrogen-responsive gene expression.
Curtis CD; Likhite VS; McLeod IX; Yates JR; Nardulli AM
Cancer Res; 2007 Nov; 67(21):10600-7. PubMed ID: 17975005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
